Country Offices Contact Share

Global threat from drug resistant HIV in sub-Saharan Africa

Since its introduction 16 years ago, combination antiretroviral therapy for HIV infection has saved millions of lives.

Roll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance. Raph Hamers and colleagues call for improved patient management and the integration of population based drug resistance surveillance into national treatment programmes

Suggested further reads